Data Tables

View HTML		View PDF
Section I
1.1	U.S. Organ Donors by Organ and Donor Type, 1997 to 2006	(29 k)
1.2	Number of Organs Recovered from Deceased Donors, 1997 to 2006	(24 k)
1.3	Waiting List at End of Year, 1997 to 2006	(27 k)
1.4	Characteristics of Waiting List Patients at End of Year, 1997 to 2006	(36 k)
	Age
	Blood Type
	Residency
	Gender
	Previous Transplant Any Organ
	Race
	Patient Status
1.5	Time to Transplant New Waiting List Registrations, 1997 to 2006	(35 k)
1.6	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk Waiting List, 1997 to 2006	(29 k)
1.7	Transplants by Organ and Donor Type, 1997 to 2006	(29 k)
1.8	Multi-Organ Transplants, 1997 to 2006	(26 k)
1.9a	Immunosuppression Use by Organ in 2005 and 2006	(34 k)
1.9b	Immunosuppression Use by Organ Maintenance Regimen at Discharge, 2006 Transplants	(31 k)
1.9c	Immunosuppression Use by Organ Maintenance Regimen at One Year Following Transplantation 2005 Transplants	(31 k)
1.10	Transplant Recipient Characteristics, 1997 to 2006	(36 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Previous Transplant Any Organ
	Payment Source
1.11a	One Year Adjusted Graft Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.11b	One Year Unadjusted Graft Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.12a	One Year Adjusted Patient Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.12b	One Year Unadjusted Patient Survival by Organ and Year of Transplant, 1996 to 2005	(31 k)
1.13	Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years Standard Errors of the Survival Rates	(37 k)
	Standard Errors of the Survival Rates
	Survival (%)
	Number of Transplants For This Survival Analysis
1.14	Prevalence of People Living with a Functioning Transplant at End of Year 1997 to 2005	(20 k)
Section II
2.1	Deceased Donor Characteristics, 1997 to 2006 Deceased Donors of Any Organ	(45 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.2	Deceased Donor Characteristics, 1997 to 2006 Kidney Donors	(47 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Race
	Donor Type
2.3	Deceased Donor Characteristics, 1997 to 2006 Pancreas Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.4	Deceased Donor Characteristics, 1997 to 2006 Liver Donors	(45 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.5	Deceased Donor Characteristics, 1997 to 2006 Intestine Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.6	Deceased Donor Characteristics, 1997 to 2006 Heart Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Race
2.7	Deceased Donor Characteristics, 1997 to 2006 Lung Donors	(44 k)
	Age
	Blood Type
	Cause of Death
	Circumstance of Death
	Mechanism of Death
	Gender
	Donation After Cardiac Death
	Race
2.8	Living Donor Characteristics, 1997 to 2006 Living Donors of Any Organ	(35 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.9	Living Donor Characteristics, 1997 to 2006 Kidney Donors	(35 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.10	Living Donor Characteristics, 1997 to 2006 Liver Segment Donors	(34 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.11	Living Donor Characteristics, 1997 to 2006 Lung Lobe Donors	(34 k)
	Age
	Blood Type
	Gender
	Race
	Donor Relation
2.12	Deceased Donor Organ Utilization, 1997 to 2006, Any Organ	(32 k)
2.13	Deceased Donor Organ Utilization, 1997 to 2006, Kidney	(37 k)
2.14	Deceased Donor Organ Utilization, 1997 to 2006, Pancreas	(36 k)
2.15	Deceased Donor Organ Utilization, 1997 to 2006, Liver	(36 k)
2.16	Deceased Donor Organ Utilization, 1997 to 2006, Intestine	(36 k)
2.17	Deceased Donor Organ Utilization, 1997 to 2006, Heart	(36 k)
2.18	Deceased Donor Organ Utilization, 1997 to 2006, Lung	(36 k)
Section III
3.1	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Kidney	(27 k)
3.2	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Kidney	(30 k)
3.3	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Kidney	(29 k)
3.4	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Pancreas	(27 k)
3.5	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Pancreas	(30 k)
3.6	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Pancreas	(29 k)
3.7	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Liver	(28 k)
3.8	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Liver	(29 k)
3.9	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Liver	(29 k)
3.10	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Intestine	(26 k)
3.11	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Intestine	(29 k)
3.12	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Intestine	(29 k)
3.13	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Heart	(27 k)
3.14	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Heart	(29 k)
3.15	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Heart	(29 k)
3.16	Disposition of Organs Recovered from Deceased Donors, 1997 to 2006 Lung	(27 k)
3.17	Reasons for Non-Use of Recovered Organs, 1997 to 2006 Lung	(29 k)
3.18	Reasons for Non-Recovery of Consented Organs, 1997 to 2006 Lung	(29 k)
Section IV
4.1	Deceased Donors Procured by U.S. Organ Procurement Organizations 1997 to 2006	(47 k)
4.2	Transplant Centers Within Each OPO CMS-Designated Service Area As of May 2007, By Home State of OPO	(67 k)
Section V
5.1a	Waiting List Patient Characteristics at End of Year Kidney Waiting List Active Waitlist Patients, 1997 to 2006	(44 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	PRA
	Previous Transplant Same Organ
	Time on Waiting List
5.1b	Waiting List Patient Characteristics at End of Year Kidney Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(38 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
5.2	Time to Transplant, 1997 to 2006 New Kidney Waiting List Registrations	(98 k)
	Blood Type
	Age
	Gender
	All Patient Types
	PRA
	Gender and PRA
	Race and PRA
	Previous Transplant Any Organ
	Previous Transplant and Gender
	Previous Transplant and PRA
	Previous Transplant and Race
	Race
	Residency
5.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Kidney Waiting List	(50 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
5.4	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Kidneys	(28 k)
5.4a	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor non-ECD Kidneys	(57 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Diagnosis
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
5.4b	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Expanded Criteria Donors (ECD) Kidneys	(56 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Diagnosis
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
5.4c	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor Kidneys	(55 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Relation
	Diagnosis
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
5.5	Incidence of Transplant, 1997 to 2006 Kidney Transplants per 1 Million Population	(29 k)
5.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Kidney Transplants	(29 k)
5.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Kidney Transplants	(31 k)
5.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Kidney Transplants	(29 k)
5.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Kidney Transplants	(30 k)
5.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Kidney Transplants	(31 k)
5.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Kidney Transplants	(31 k)
5.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Kidney Transplants	(31 k)
5.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Kidney Transplants	(34 k)
5.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Kidney Transplants	(30 k)
5.7a	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor non-ECD Kidney Transplantation	(89 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
	Diagnosis
5.7b	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor ECD Kidney Transplantation	(85 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
	Diagnosis
5.7c	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Kidney Transplantation	(78 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Age
	Age
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
	Diagnosis
5.8a	Adjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(39 k)
	Age
	Gender
	Race
	Diagnosis
5.8b	Adjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.8c	Adjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.9a	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(22 k)
5.9b	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.9c	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.10a	Unadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(49 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.10b	Unadjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.10c	Unadjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(49 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Relation
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Dialysis Within 1 Week of Tx
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.11a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(23 k)
5.11b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.11c	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.12a	Adjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.12b	Adjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(38 k)
	Age
	Gender
	Race
	Diagnosis
5.12c	Adjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Gender
	Race
	Diagnosis
5.13a	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(22 k)
5.13b	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.13c	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.14a	Unadjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.14b	Unadjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Age
	Diagnosis
	Dialysis Within 1 Week of Tx
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.14c	Unadjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(48 k)
	Age
	Blood Type
	Residency
	Gender
	PRA
	Race
	Center Volume
	Donor Relation
	Donor Age
	Diagnosis
	Dialysis Within 1 Week of Tx
	On Life Support at Tx
	Hospitalized at Tx
	Level of HLA Mismatch
5.15a	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants	(22 k)
5.15b	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants	(23 k)
5.15c	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants	(22 k)
5.16	Prevalence of People Living with a Functioning Transplant at End of Year Kidney Recipients, 1997 to 2005	(48 k)
	Blood Type
	Residency
	Gender
	PRA
	Race
	Donor Type
	Age
	Diagnosis
	Hospitalized at Tx
	Level of HLA Mismatch
	PRA
	Previous Transplant Same Organ
	Previous Transplant Any Organ
5.17	Transplants by State and Transplant Center, 1997 to 2006 Kidney	(95 k)
Section VI
6.1a	Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1997 to 2006	(38 k)
	Age
	Blood Type
	Residency
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
6.1b	Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(33 k)
	Age
	Gender
	Race
	Time on Waiting List
6.2	Time to Transplant, 1997 to 2006 New Pancreas Transplant Alone (PTA) Waiting List Registrations	(55 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
6.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas Transplant Alone (PTA) Waiting List	(40 k)
	Age
	Blood Type
	Gender
	Race
6.4	Transplant Recipient Characteristics, 1997 to 2006 Pancreas Transplant Alone (PTA) Recipients	(39 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Cold Ischemic Time
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
6.5	Incidence of Transplant, 1997 to 2006 Pancreas Transplant Alone (PTA) Transplants per 1 Million Population	(29 k)
6.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(29 k)
6.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
6.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(29 k)
6.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(30 k)
6.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants	(30 k)
6.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
6.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(31 k)
6.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(33 k)
6.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants	(30 k)
6.7	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) Transplantation	(66 k)
	Blood Type
	Residency
	Gender
	Race
	Donor Age
	Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
	Previous Transplant Any Organ
6.8	Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
6.9	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.10	Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
6.11	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.12	Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(30 k)
	Age
	Gender
	Race
6.13	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.14	Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Age
	Cold Ischemic Time
	Hospitalized at Tx
	Level of HLA Mismatch
6.15	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants	(22 k)
6.16	Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1997 to 2005	(37 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
6.17	Transplants by State and Transplant Center, 1997 to 2006 Pancreas Transplant Alone (PTA)	(54 k)
Section VII
7.1a	Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1997 to 2006	(37 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Previous Transplant Same Organ
	Time on Waiting List
7.1b	Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(33 k)
	Age
	Gender
	Race
	Time on Waiting List
7.2	Time to Transplant, 1997 to 2006 New Pancreas After Kidney (PAK) Waiting List Registrations	(49 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Race
	Residency
7.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas After Kidney (PAK) Waiting List	(39 k)
	Age
	Blood Type
	Gender
	Race
7.4	Transplant Recipient Characteristics, 1997 to 2006 Pancreas After Kidney (PAK) Recipients	(39 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Cold Ischemic Time
	Hospitalized at Tx
	Previous Transplant Same Organ
	Payment Source
7.5	Incidence of Transplant, 1997 to 2006 Pancreas After Kidney (PAK) Transplants per 1 Million Population	(29 k)
7.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants	(29 k)
7.6b	Immunosuppression Use for Induct